“…All of the cases were histological, pathologically or cytological confirmed as cervical cancer, of them, five studies did not distinguish the type (CC) (Slattery et al, 1989;Tajima et al, 1990;SettheethamIshida et al, 2004;Sobti et al, 2006;Sobti et al, 2008), four studies clearly divided indicated the type (CIN) and divided according to their pathologic stage (CIN 1, 2, or 3) (Wu et al, 2003;Sull et al, 2004;Wu et al, 2004;Tsai et al, 2007), two studies clearly divided the type to HSIL and LSIL (Coker et al, 2002;Tay et al, 2004), one study reported ICC (Sull et al, 2004). Controls were mainly healthy populations, and matched with age, gender, or cancer-free, six were hospital-based (HB) (Slattery et al, 1989;Tajima et al, 1990;Settheetham-Ishida et al, 2004;Sull et al, 2004;Tay et al, 2004;Sobti et al, 2006;Sobti et al, 2008), five were population-based (PB) (Coker et al, 2002;Wu et al, 2003;Wu et al, 2004;Tsai et al, 2007). There were three studies performed in Taiwan of China (Wu et al, 2003;Wu et al, 2004;Tsai et al, 2007), two in the USA (Slattery et al, 1989;Coker et al, 2002), two in India (Sobti et al, 2006;Sobti et al, 2008), one in Japan (Tajima et al, 1990), one in Thailand (SettheethamIshida et al, 2004), one in Korea (Sull et al, 2004), and one in Singapore (Tay et al, 2004).…”